Tal Nawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tal Nawy has a total of 570 co-authors. Here are the top co-authors by number of shared publications:
- Dana Pe’er
Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, USA
44 shared publications - Ronan Chaligne
Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, USA
38 shared publications - Linas Mazutis
Institute of Biotechnology Vilnius University
37 shared publications - Ignas Masilionis
Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
34 shared publications - Yubin Xie
Memorial Sloan Kettering Cancer Center 1 Computational and Systems Biology Program New York, New York
34 shared publications - Itsik Pe’ER
Columbia University 2 Department of Computer Science, Fu Foundation School of Engineering & Applied Science New York, New York
32 shared publications
Latest Publications
- 19 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8128) , E25-E31
Artefacts in single-cell mtDNA analyses misinform phylogenies
- 19 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8128) , E25-E31
Artefacts in single-cell mtDNA analyses misinform phylogenies
- Open Access
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8128) , E43
Publisher Correction: Progressive plasticity during colorectal cancer metastasis
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8128) , E43
Open AccessPublisher Correction: Progressive plasticity during colorectal cancer metastasis
- Open Access
Hierarchical classification of immune cell transcriptomes at population-scale
Accurate immune cell classification is essential for interpreting single-cell RNA sequencing (scRNA-seq) data. However, progress in automating cell type annotation is constrained by the lack of independent, high-resolution benchmarks, as routine data integration introduces statistical dependencies that inflate model generalizability. Here, we present the single-cell universal classification omnibus (Suco), a resource of independent, uniform expert annotations, and Compocyte, a modular hierarchical classifier. Together, they establish a framework that substantially outperforms existing classifiers while facilitating expert review of ambiguous annotations. Applying Compocyte across 50 studies, including three newly generated datasets, we classified 15.6 million leukocytes from 3,965 patients. Within this cohort, we identified a new tumor-associated resorptive macrophage phenotype, a non-canonical monocyte subtype in subclinical cytokine release syndrome, and the programmatic erosion of T cell memory stemness across metastatic sites. Suco and Compocyte thus provide a generalizable framework to uncover the principles governing human immunity at population scale.
Open AccessHierarchical classification of immune cell transcriptomes at population-scale
Accurate immune cell classification is essential for interpreting single-cell RNA sequencing (scRNA-seq) data. However, progress in automating cell type annotation is constrained by the lack of independent, high-resolution benchmarks, as routine data integration introduces statistical dependencies that inflate model generalizability. Here, we present the single-cell universal classification omnibus (Suco), a resource of independent, uniform expert annotations, and Compocyte, a modular hierarchical classifier. Together, they establish a framework that substantially outperforms existing classifiers while facilitating expert review of ambiguous annotations. Applying Compocyte across 50 studies, including three newly generated datasets, we classified 15.6 million leukocytes from 3,965 patients. Within this cohort, we identified a new tumor-associated resorptive macrophage phenotype, a non-canonical monocyte subtype in subclinical cytokine release syndrome, and the programmatic erosion of T cell memory stemness across metastatic sites. Suco and Compocyte thus provide a generalizable framework to uncover the principles governing human immunity at population scale.
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Differentially expressed and modular genes for each archetype cluster, including upregulated genes (log₂ fold change > 1, p < 0.05) and Hotspot-identified informative genes with significant autocorrelation (FDR < 0.05)
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Differentially expressed and modular genes for each archetype cluster, including upregulated genes (log₂ fold change > 1, p < 0.05) and Hotspot-identified informative genes with significant autocorrelation (FDR < 0.05)
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Expression and histological evidence of lipid metabolism in peritoneal metastases, showing up-regulation of lipid anabolism and oxidative stress pathways in archetype 2 cancer cells
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Expression and histological evidence of lipid metabolism in peritoneal metastases, showing up-regulation of lipid anabolism and oxidative stress pathways in archetype 2 cancer cells
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Table S10 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Expert-curated gene sets and associated references compiled for pathway and enrichment analyses performed in this study
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S10 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Expert-curated gene sets and associated references compiled for pathway and enrichment analyses performed in this study
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Overview of the archetype analysis framework and its application to single-cell transcriptomes from metastatic organ sites in the rapid autopsy PDAC dataset
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Overview of the archetype analysis framework and its application to single-cell transcriptomes from metastatic organ sites in the rapid autopsy PDAC dataset
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Overview and benchmarking of IntegrateCNV and PICASSO methods for inferring single-cell copy number alterations and reconstructing subclonal phylogenies in metastatic PDAC
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Overview and benchmarking of IntegrateCNV and PICASSO methods for inferring single-cell copy number alterations and reconstructing subclonal phylogenies in metastatic PDAC
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Table S11 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Names of samples, whole-exome sequencing EGA file IDs, and snRNA-seq HTAN file IDs
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S11 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Names of samples, whole-exome sequencing EGA file IDs, and snRNA-seq HTAN file IDs
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Data from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Metastasis is the leading cause of cancer deaths. To develop strategies for intercepting metastatic progression, a better understanding of how tumor cells adapt to vastly different organ contexts is needed. To investigate this question, a single-cell transcriptomic atlas of primary tumors and diverse metastatic samples (liver, omentum, peritoneum, stomach wall, lymph node, and diaphragm) from a patient with pancreatic ductal adenocarcinoma who underwent rapid autopsy was generated. Using unsupervised archetype analysis, both shared and site-specific gene programs were identified, including lipid metabolism and gastrointestinal programs prevalent in peritoneal and stomach wall lesions, respectively. We developed phylogenetic inference from copy-number alterations in single-cell sequencing observations (PICASSO) as a probabilistic approach for inferring clonal phylogeny from single-cell and matched whole-exome sequencing data. Comparison of PICASSO-generated clonal structure with phenotypic signatures revealed that pancreatic cancer cells adapted to local environments with minimal contribution from clonal genotype. Our results suggest a paradigm whereby strong environmental effects are imposed on highly plastic cancer cells during metastatic dissemination.Significance:Single-cell transcriptional profiling of primary tumor and metastases from rapid autopsy samples of an individual with pancreatic cancer, combined with probabilistic clonal inference by PICASSO, reveals substantial transcriptomic plasticity in metastatic cells.This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Metastasis is the leading cause of cancer deaths. To develop strategies for intercepting metastatic progression, a better understanding of how tumor cells adapt to vastly different organ contexts is needed. To investigate this question, a single-cell transcriptomic atlas of primary tumors and diverse metastatic samples (liver, omentum, peritoneum, stomach wall, lymph node, and diaphragm) from a patient with pancreatic ductal adenocarcinoma who underwent rapid autopsy was generated. Using unsupervised archetype analysis, both shared and site-specific gene programs were identified, including lipid metabolism and gastrointestinal programs prevalent in peritoneal and stomach wall lesions, respectively. We developed phylogenetic inference from copy-number alterations in single-cell sequencing observations (PICASSO) as a probabilistic approach for inferring clonal phylogeny from single-cell and matched whole-exome sequencing data. Comparison of PICASSO-generated clonal structure with phenotypic signatures revealed that pancreatic cancer cells adapted to local environments with minimal contribution from clonal genotype. Our results suggest a paradigm whereby strong environmental effects are imposed on highly plastic cancer cells during metastatic dissemination.Significance:Single-cell transcriptional profiling of primary tumor and metastases from rapid autopsy samples of an individual with pancreatic cancer, combined with probabilistic clonal inference by PICASSO, reveals substantial transcriptomic plasticity in metastatic cells.This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.